Nancy Krunic
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Chronic Myeloid Leukemia Treatments 4
-
- Peroxisome Proliferator-Activated Receptors 2
- Advanced biosensing and bioanalysis techniques 1
- Co-authors
- Francis J. Giles (2 shared papers)Tamás Masszi (3 shared papers)Giuseppe Saglio (3 shared papers)Véronique Bédoucha (3 shared papers)Eibhlin Conneally (3 shared papers)Jesper Stentoft (3 shared papers)Susanne Saußele (3 shared papers)Philipp D. le Coutre (3 shared papers)
- Journals
- Developmental Brain Research (3 papers)Leukemia (1 paper)Annals of the New York Academy of Sciences (1 paper)Journal of Clinical Oncology (1 paper)Blood (1 paper)
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Nancy Krunic
9 papers receiving 419 citations
Peers
Comparison fields: 5 of 46
- Hematology 317
- Genetics 265
- Rheumatology 159
- Oncology 84
- Infectious Diseases 44
Countries citing papers authored by Nancy Krunic
This map shows the geographic impact of Nancy Krunic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Krunic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Krunic more than expected).
Fields of papers citing papers by Nancy Krunic
This network shows the impact of papers produced by Nancy Krunic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Krunic. The network helps show where Nancy Krunic may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Krunic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 203 | |
| 2 | 2018 | 104 | |
| 3 | 2007 | 60 | |
| 4 | 2016 | 16 | |
| 5 | 2011 | 14 | |
| 6 | 1997 | 10 | |
| 7 | 2016 | 8 | |
| 8 | 2000 | 7 | |
| 9 | 2000 | 5 |
About Nancy Krunic
Nancy Krunic is a scholar working on Hematology, Molecular Biology, Genetics, Physiology and Infectious Diseases, having authored 9 papers that have together received 427 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Neonatal and fetal brain pathology (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), HER2/EGFR in Cancer Research (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Hematology (317 citations), Genetics (265 citations), Rheumatology (159 citations), Oncology (84 citations) and Infectious Diseases (44 citations). Nancy Krunic has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Francis J. Giles, Tamás Masszi, Giuseppe Saglio, Véronique Bédoucha, Eibhlin Conneally, Jesper Stentoft, Susanne Saußele, Philipp D. le Coutre, Jerald P. Radich and Andreas Hochhaus. Their work appears in journals such as Developmental Brain Research, Leukemia, Annals of the New York Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.